nucleoside drugs
Showing 1 - 25 of >10,000
HIV Trial (Lipovirtide 10mg, Lipovirtide 40mg, Lipovirtide 60mg)
Not yet recruiting
- HIV
- Lipovirtide 10mg
- +3 more
- (no location specified)
Sep 23, 2023
Long-term Oral Anti Hepatitis B Nucleoside Analogs and Hepatic
Enrolling by invitation
- Hepatic Steatosis
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Jun 9, 2022
Antiviral Therapy for Patients With Liver Cancer After Surgery
Recruiting
- Hepatocellular Carcinoma
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Jul 19, 2022
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Efavirenz)
Completed
- HIV Infections
- Indinavir sulfate
- +2 more
-
Los Angeles, California
- +55 more
Oct 28, 2021
Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)
Recruiting
- Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
- TQB2618 injection azacitidine, AZA decitabine, DAC
-
ChengDu, Sichuan, ChinaWest China Hospital of Sichuan University
Jun 16, 2022
HIV Trial in United States (Abacavir sulfate, Emtricitabine, Lamivudine)
Completed
- HIV Infections
- Abacavir sulfate
- +6 more
-
Chicago, Illinois
- +3 more
Oct 28, 2021
HIV-1 Infection Trial in France (Samplings)
Recruiting
- HIV-1 Infection
- Samplings
-
Clamart, France
- +6 more
Jan 4, 2022
Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)
Completed
- Neoplasms
- FdCyd + THU
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt
Not yet recruiting
- HIV-1-infection
- Therapeutic drug monitoring in plasma of mother and child and in breastmilk
- (no location specified)
Nov 29, 2022
Bictegravir in the Elderly Living With HIV (BICEP)
Active, not recruiting
- HIV-1-infection
- Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
-
Buffalo, New YorkEvergreen Health
Oct 28, 2022
Hepatitis B Trial in Changsha (Peripheral iv)
Recruiting
- Hepatitis B
- Peripheral iv
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Jul 20, 2022
Tenofovir Disoproxil Fumarate and Entcavir in Treatment of
Recruiting
- Chronic Hepatitis b Patients
- Tenofovir Disoproxil Fumarate and Entcavir
-
Sohag, EgyptSohag University hospitals
May 22, 2023
Chronic Hepatitis b Trial (active comarator using antiviral drug of nucleoside analogues, HA+purification)
Not yet recruiting
- Chronic Hepatitis b
- active comarator using antiviral drug of nucleoside analogues
- HA+purification
- (no location specified)
Mar 16, 2021